| 2024 |
Effect of Poria cocos terpenes: Verifying modes of action using molecular docking, drug-induced transcriptomes, and diffusion network analyses |
| 2024 |
Antisense-mediated Splicing Correction as a Therapeutic Approach for p53 K120R mutation |
| 2023 |
An ethanol extract of Coptidis rhizoma induces apoptotic cell death in induced pluripotent stem cells and suppresses teratoma formation |
| 2023 |
Neuroprotective Effects of Licochalcone D in Oxidative-Stress-Induced Primitive Neural Stem Cells from Parkinson's Disease Patient-Derived iPSCs |
| 2022 |
Paeoniflorin alleviates skeletal muscle atrophy in ovariec-tomized mice through the ERa/NRF1 mitochondrial biogenesis pathway |
| 2022 |
Caffeic acid selectively eliminates teratogenic humna-induced pluripotent stem cells via apoptotic cell death |
| 2021 |
Differential transcriptional regulation of polymorphic p53 codon 72 in metabolic pathways |
| 2021 |
Ciliogenesis is Not Directly Regulated by LRRK2 Kinase Activity in Neurons |
| 2020 |
Quantitative Proteomic Analysis of Primitive Neural Stem Cells from LRRK2 G2019S-Associated Parkinson’s Disease Patient-Derived iPSCs |
| 2020 |
Ethanol extract of Magnoliae Cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway |
| 2020 |
Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through the p53-Mediated Apoptosis |
| 2020 |
Elimination of Teratogenic Human Induced Pluripotent Stem Cells by Bee Venom via calcium-calpain pathway |
| 2019 |
Generation of gene-corrected iPSC line, KIOMi002-A, from Parkinson's disease patient iPSC with LRRK2 G2019S mutation using BAC-based homologous recombination |
| 2018 |
K120R mutation inactivates p53 by creating an aberrant splice site leading to nonsense-mediated mRNA decay |
| 2018 |
Generation of gene-corrected iPSC line from Parkinson’s disease patient iPSC line with alpha-SNCA A53T mutation |
| 2017 |
The five elements of the cell |
| 2016 |
Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC |
| 2016 |
Integrating Gene Correction in the Reprogramming and Transdifferentiation Processes: A One-Step Strategy to Overcome Stem Cell-Based Gene Therapy Limitations |
